share_log

FDA Concluded New Regulatory Pathway For CBD Is Needed That Balances Individuals' Desire For Access To CBD Products; FDA Convened High-Level Internal Working Group To Explore Potential Regulatory Pathways For CBD Products

FDA Concluded New Regulatory Pathway For CBD Is Needed That Balances Individuals' Desire For Access To CBD Products; FDA Convened High-Level Internal Working Group To Explore Potential Regulatory Pathways For CBD Products

FDA 總結了需要 CBD 的新監管途徑,以平衡個人獲得 CBD 產品的願望; FDA 召集了高級內部工作組,以探索 CBD 產品的潛在監管途徑
Benzinga Real-time News ·  2023/01/26 11:09

FDA Concluded New Regulatory Pathway For CBD Is Needed That Balances Individuals' Desire For Access To CBD Products; FDA Convened High-Level Internal Working Group To Explore Potential Regulatory Pathways For CBD Products

FDA 總結了需要 CBD 的新監管途徑,以平衡個人獲得 CBD 產品的願望; FDA 召集了高級內部工作組,以探索 CBD 產品的潛在監管途徑

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論